Literature DB >> 12100127

Prevention and treatment of viral infections in stem cell transplant recipients.

Per Ljungman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100127     DOI: 10.1046/j.1365-2141.2002.03515.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

1.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

2.  Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Authors:  Rafet Basar; May Daher; Nadima Uprety; Elif Gokdemir; Abdullah Alsuliman; Emily Ensley; Gonca Ozcan; Mayela Mendt; Mayra Hernandez Sanabria; Lucila Nassif Kerbauy; Ana Karen Nunez Cortes; Li Li; Pinaki P Banerjee; Luis Muniz-Feliciano; Sunil Acharya; Natalie W Fowlkes; Junjun Lu; Sufang Li; Stephan Mielke; Mecit Kaplan; Vandana Nandivada; Mustafa Bdaiwi; Alexander D Kontoyiannis; Ye Li; Enli Liu; Sonny Ang; David Marin; Lorenzo Brunetti; Michael C Gundry; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2020-07-28

3.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

4.  Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.

Authors:  Christopher B Whitehurst; Marcia K Sanders; Mankit Law; Fu-Zhang Wang; Jie Xiong; Dirk P Dittmer; Joseph S Pagano
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

5.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Authors:  Rodrigo Martino; Rocío Parody Porras; Nuria Rabella; John V Williams; Elena Rámila; Nuria Margall; Rosa Labeaga; James E Crowe; Pedro Coll; Jorge Sierra
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

6.  Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.

Authors:  Cedar J Fowler; Jennifer Dunlap; Darcy Troyer; Peter Stenzel; Elliot Epner; Richard T Maziarz
Journal:  Adv Hematol       Date:  2010-06-16

7.  Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Authors:  Karim Sacre; Stéphanie Nguyen; Claire Deback; Guislaine Carcelain; Jean-Paul Vernant; Véronique Leblond; Brigitte Autran; Nathalie Dhedin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

8.  Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.

Authors:  Fu-Zhang Wang; Debasmita Roy; Edward Gershburg; Christopher B Whitehurst; Dirk P Dittmer; Joseph S Pagano
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

9.  A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

Authors:  Nicole A Karras; Matthew Weeres; Wendy Sessions; Xiyan Xu; Todd Defor; Jo-Anne H Young; Heather Stefanski; Claudio Brunstein; Sarah Cooley; Jeffrey S Miller; Bruce R Blazar; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-29       Impact factor: 5.742

Review 10.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.